CN104288464A - Traditional Chinese medicine for treating cardio-cerebrovascular diseases - Google Patents

Traditional Chinese medicine for treating cardio-cerebrovascular diseases Download PDF

Info

Publication number
CN104288464A
CN104288464A CN201410571208.9A CN201410571208A CN104288464A CN 104288464 A CN104288464 A CN 104288464A CN 201410571208 A CN201410571208 A CN 201410571208A CN 104288464 A CN104288464 A CN 104288464A
Authority
CN
China
Prior art keywords
parts
radix
chinese medicine
blood
traditional chinese
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410571208.9A
Other languages
Chinese (zh)
Inventor
李晓丽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410571208.9A priority Critical patent/CN104288464A/en
Publication of CN104288464A publication Critical patent/CN104288464A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/236Ligusticum (licorice-root)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/62Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/21Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258Panax (ginseng)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/286Carthamus (distaff thistle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481Astragalus (milkvetch)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/488Pueraria (kudzu)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/51Gentianaceae (Gentian family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537Salvia (sage)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/65Paeoniaceae (Peony family), e.g. Chinese peony
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/888Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/889Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/896Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A61K36/8962Allium, e.g. garden onion, leek, garlic or chives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine for treating cardio-cerebrovascular diseases, belonging to the technical field of traditional Chinese medicines. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 10-15 parts of Szechuan lovage rhizome, 10-15 parts of safflower, 10-15 parts of dragon's blood, 15-20 parts of radix notoginseng, 5-10 parts of radix salviae miltiorrhizae, 15-20 parts of leech, 10-15 parts of rosewood heart wood, 5-10 parts of red paeony root, 5-10 parts of kudzuvine root, 5-10 parts of ginkgo leaves, 10-15 parts of membranous milkvetch root, 5-10 parts of American ginseng, 3-5 parts of musk, 10-15 parts of twotooth achyranthes root, 15-10 parts of longstamen onion bulb, 5-10 parts of grassleaf sweelflag rhizome, 10-15 parts of largeleaf gentian root and 5-10 parts of Chinese angelica. The traditional Chinese medicine provided by the invention has scientific and reasonable formula, unique compatibility and effects of promoting blood circulation, removing blood stasis, smoothing qi and blood and the like, can dilate blood vessels, increase blood flow and improve cardio-cerebrovascular circulation, is in line with traditional Chinese medicine theory and has a significant curative effect against the cardio-cerebrovascular diseases; and furthermore, a making method of the traditional Chinese medicine is simple, convenient and easy to operate, and the traditional Chinese medicine is convenient to take, short in treatment course and rapid in onset of action, has no toxicity or side effects, can not form medicament dependence and has good economic and social benefits.

Description

A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease
Technical field
The present invention relates to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, belong to traditional Chinese medical science medical art.
Background technology
Cardiovascular and cerebrovascular disease causes the disease of heart and brain tissues blood supply disorder because of cardio cerebrovascular affection.Heart disease main manifestations is coronary heart disease and angina pectoris.Cerebrovascular main manifestations is hemorrhagic apoplexy and ischemic cerebrovascular.Current, the cardiovascular and cerebrovascular diseases such as cerebral arteriosclerosis, coronary heart diseases and angina pectoris, cerebral thrombosis, cerebral infarction, cerebral hemorrhage have become the healthy frequently-occurring disease of a kind of serious harm person in middle and old age and common property disease, have the advantages that sickness rate is high, disability rate is high, mortality rate is high, relapse rate is high, complication is many, it is reported, the number of cardiovascular and cerebrovascular disease is died from every year up to 1,500 ten thousand people in the whole world, occupies the various cause of the death the first.China dies from nearly 3,000,000 people of cardiovascular and cerebrovascular disease every year, accounts for 51% of the annual total Death causes of China.Therefore, the control of cardiovascular and cerebrovascular disease has become the problem of society and medical circle extensive concern.
At present, the treatment of cardiovascular and cerebrovascular disease generally adopts comprehensive therapy, comprise Western medicine colligation treatment, traditional medicine synthetic therapy and Integrative medicine therapy, wherein better with Integrative medicine therapy effect in mortality rate and disability rate, but still lack effective medicine.The compound medicines function singleness of current treatment cardiovascular and cerebrovascular disease, drug matching is mixed and disorderly, take effect slowly, and Western medicine can only take the way of blood vessel dilating, can only temporary relieve, cure the symptoms, not the disease, and the recovery process of cardiovascular and cerebrovascular disease is very long, need long-term prescription to treat, easily form the dependency to medicine.Therefore, be badly in need of a kind of taking convenience, short treating period, instant effect, have no side effect and the medicine of drug dependence can not be formed.
Summary of the invention
The object of the invention is to, a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease is provided, solves above technical problem.
For solving the problem, the technical solution adopted in the present invention is:
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is characterized in that: it is made up of following composition of raw materials: Rhizoma Chuanxiong 10-15 part, Flos Carthami 10-15 part, Sanguis Draxonis 10-15 part, Radix Notoginseng 15-20 part, Radix Salviae Miltiorrhizae 5-10 part, Hirudo 15-20 part, Lignum Dalbergiae Odoriferae 10-15 part, Radix Paeoniae Rubra 5-10 part, Radix Puerariae 5-10 part, Folium Ginkgo 5-10 part, Radix Astragali 10-15 part, Radix Panacis Quinquefolii 5-10 part, Moschus 3-5 part, Radix Achyranthis Bidentatae 10-15 part, Bulbus Allii Macrostemonis 5-10 part, Rhizoma Acori Graminei 5-10 part, Radix Gentianae Macrophyllae 10-15 part, Radix Angelicae Sinensis 5-10 part.
Say further, the Chinese medicine of described treatment cardiovascular and cerebrovascular disease, is made up of following composition of raw materials: Rhizoma Chuanxiong 12 parts, 12 parts, Flos Carthami, Sanguis Draxonis 12 parts, Radix Notoginseng 18 parts, Radix Salviae Miltiorrhizae 8 parts, Hirudo 18 parts, Lignum Dalbergiae Odoriferae 12 parts, Radix Paeoniae Rubra 8 parts, Radix Puerariae 8 parts, Folium Ginkgo 8 parts, the Radix Astragali 12 parts, Radix Panacis Quinquefolii 8 parts, 4 parts, Moschus, Radix Achyranthis Bidentatae 12 parts, Bulbus Allii Macrostemonis 8 parts, Rhizoma Acori Graminei 8 parts, Radix Gentianae Macrophyllae 12 parts, Radix Angelicae Sinensis 8 parts.
The property of medicine, the pharmacology of the Chinese medicine used in the formula of medicine of the present invention are as follows:
Rhizoma Chuanxiong: acrid in the mouth, warm in nature; Return liver, gallbladder, heart channel.Gas perfume rises loose, can blood circulation promoting and blood stasis dispelling, again can promoting the circulation of QI to relieve pain, is " the gas medicine in blood ", the sensible QI and blood effect of tool, therefore controls the breast side of body, all pains of abdominal part of qi depression to blood stasis.Containing ligustrazine in Rhizoma Chuanxiong, energy coronary artery dilator, increases coronary artery blood flow, improves the blood oxygen supply of cardiac muscle, and the oxygen consumption of reduction cardiac muscle; And the expansible cerebrovascular of ligustrazine, reduces vascular resistance, significantly increases brain and LBF amount, improves microcirculation, can also reduce surface activity of blood platelet, suppresses platelet aggregation, the formation of pre-preventing thrombosis.
Flos Carthami: acrid in the mouth, warm in nature; Enter the heart, Liver Channel.There is the effect such as promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving; Cure mainly: amenorrhea, lump in the abdomen, difficult labour, stillborn fetus, disease that postpartum lochia can't go, blood stasis are had a pain, carbuncle, injury from falling down.
Sanguis Draxonis: sweet in the mouth, salty, property is put down; Enter the heart, liver, spleen channel.There is dissipating blood stasis analgesic therapy, the effects such as hemostasia and promoting granulation; Cure mainly: traumatic injury is lost, ecchymoma due to internal injury, continuous bleeding due to traumatic injury, scrofula, ecthyma unhealed for long time.
Radix Notoginseng: sweet in the mouth, micro-hardship, warm in nature; Enter liver, stomach, large intestine channel.There is the effects such as hemostasis, dissipating blood stasis, detumescence, analgesic therapy.Cure mainly: spit blood, hemoptysis, epistaxis, has blood in stool, dysentery, metrorrhagia, lump in the abdomen, puerperal blood faints, and retention of lochia falls and flutters blood stasis, traumatic hemorrhage, carbuncle pain.
Radix Salviae Miltiorrhizae: bitter in the mouth, cold nature; GUIXIN, Liver Channel.There is promoting blood flow to regulate menstruation, stasis-dispelling and pain-killing, removing heat from blood eliminating carbuncle, clear away heart-fire the effect such as relieving restlessness, nourishing blood to tranquillize the mind; Cure mainly: menoxenia, amenorrhea dysmenorrhea, lump in the abdomen, breast ventral spine pain, pyretic arthralgia pain, skin infection are swollen and ache, dysphoria and insomnia, hepatosplenomegaly, angina pectoris.
Hirudo: salty in the mouth, hardship, property is put down, poisonous; Enter liver, urinary bladder channel.Hirudo has increasing action to a certain degree to cardiac muscle nutritional blood flow, has protective effect to tissue ischemia anoxia.Hirudin can resist the rabbit coronary vasospasm that pituitrin causes, and has the therapeutical effect suppressing myocardial ischemia.Hirudo can obviously be disappeared atherosclerosis of aorta speckle, makes collagen fiber hyperplasia in speckle, and cholesterol crystal reduces, and has potential using value to preventing and treating atherosclerosis.
Lignum Dalbergiae Odoriferae: acrid in the mouth, warm in nature, there is promoting flow of QI and blood, the effect of detumescence and promoting granulation.For epigastric pain, hypochondriac pain due to stagnation of liverQI, thoracic obstruction twinge, injury from falling down, traumatic hemorrhage.Now change pharmacological research to show, Lignum Dalbergiae Odoriferae has the effect increasing coronary flow, inhibition thrombosis, and its composition playing anticoagulation may be Constituents of The Essential Oil.
Radix Paeoniae Rubra: bitter in the mouth, cold nature; Return Liver Channel.There is the effect such as clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling.Cure mainly: maculae caused by violent heat pathogen; Hematemesis and epistaxis; Discharging fresh blood stool; Conjunctival congestion and swelling pain; Carbuncle skin infection; Amenorrhea; Dysmenorrhea; Metrorrhagia and leukorrhagia stranguria with turbid discharge; The stagnant hypochondriac pain of the stasis of blood; Hernia abdominal mass is gathered; Injury from falling down.
Radix Puerariae: having induces sweat brings down a fever, the function of promoting the production of body fluid to quench thirst, antidiarrheal, and the symptom such as stiffness of the nape, dizziness, headache, tinnitus of hypertensive patient can be improved, its effective ingredient is daizeol (daidzein), yellow glycoside (daidzin) and puerarin (puerarin) etc.Radix Puerariae total flavones and puerarin energy significantly coronary artery dilator, may be the effect of directly lax vascular smooth muscle, can also reduce the oxygen consumption in normal myocardium and myocardial infarction district, have and strengthen the myocardium effect to ischemic tolerance.Puerarin is a kind of beta-blockers, has obvious hypotensive effect, improves significantly to the blood flow tool of around blood capillary and cerebrovascular disorders, reduces vascular resistance, increases blood flow.
Folium Ginkgo: mildly bitter flavor, property is put down.There is the beneficial heart, promoting blood circulation and stopping pain, astringe the lung relieving asthma, effect of removing dampness antidiarrheal.The composition of valuable pharmacological active function is had to have in Folium Ginkgo: ginkgo flavonoid glycoside and ginkgolide.Silver amarolide and flavonoid glycoside have synergism, and expansible blood vessel, increase blood flow, improve cardiovascular and cerebrovascular circulation, under anaerobic conditions protect brain and myocardial cell.Triglyceride in blood can be reduced in addition, and improve hdl concentration, improve the activity of erythrocyte superoxide dismutase.Therefore the preparation of Folium Ginkgo extract all has comparatively good effect to coronary heart diseases and angina pectoris, hyperlipidemia and the patient such as cerebral concussion, cerebral trauma sequela, and generally rarely occurring untoward reaction, is easily that people accept as health medicine.
The Radix Astragali: have effect that benefiting QI for strengthening the superficies, arresting sweating are admittedly de-, hold in the palm skin ulcer granulation promoting, inducing diuresis to remove edema.The immunologic function of Radix Astragali energy enhancing body, the ability of enhanced virus inducement interferon, enhancing body anoxia enduring and stress ability, improve cardiac function, blood pressure lowering, hepatoprotective effect, regulates blood glucose, antibacterial and antiviral effect, hormone-like effect.Be used for the treatment of the deficiency of vital energy weak, sinking of QI of middle-JIAO, chronic diarrhea proctoptosis, metrorrhagia of having blood in stool, exterior deficiency spontaneous perspiration, carbuncle difficulty is burst, and burst for a long time and do not hold back, blood deficiency and yellow complexion, interior-heat is quenched one's thirst, chronic nephritis, albuminuria, diabetes etc.
Radix Panacis Quinquefolii: can boosting qi and nourishing yin, clearing away heat and promoting production of body fluid.Lose for deficiency of vital energy the moon, interior-heat, cough with asthma expectorant blood, deficiency-heat is tired of tired, quenches one's thirst, dryness of the mouth and throat.Radix Panacis Quinquefolii has resisting fatigue, antioxidation, anti-stress, anticoagulant, reduction blood coagulability, arrhythmia, resists myocardial ischemia, anti-cardiac muscle oxidation, strengthening cardiac contractility ability, improve immunity of organisms, regulate the effects such as blood glucose.
Moschus: be the one of Chinese crude drug, its medicinal source is Moschus moschiferous section animal, as the dry secretions in the male body glandular sac that woods Moschus moschiferous, horse Moschus moschiferous or former Moschus moschiferous etc. are ripe.Warm in nature, nontoxic, bitter in the mouth; Enter the heart, spleen, Liver Channel.Have and have one's ideas straightened out, ward off dirty, dredging collateral, scattered silt function.Cure mainly: apoplexy, syncope due to accumulation of phlegm, infantile convulsion, attacked by pestiferous factors unhappiness, trusted subordinate's sudden pain, traumatic injury, swollen ulcer drug.Many clinical materials show, during patients with coronary heart disease angina pectoris attacks, or be in faint shock time, take with Moschus be main component Soviet Union close ball, the state of an illness can be eased.
Radix Achyranthis Bidentatae: sweet in the mouth, hardship, acid, property is put down; Enter liver, kidney channel.Life uses dissipating blood stasis blood, subduing inflammation, controls gonorrhea, hematuria, amenorrhea, lump in the abdomen, difficult labour, retention of placenta, and postnatal blood stasis is suffered from abdominal pain, sore throat, carbuncle, traumatic injury; Ripe invigorating the liver and kidney, bone and muscle strengthening, controls waist kneecap pain, spasm of the limbs, flaccidity syndrome and arthralgia syndrome.
Bulbus Allii Macrostemonis: acrid in the mouth, hardship, warm in nature; GUIXIN, lung, stomach, large intestine channel.There is effect of activating YANG and eliminating stagnation, circulation of qi promoting intestinal stasis relieving, can be used for obstruction of qi in the chest and cardialgia, gastral cavity abdomen feeling of fullness distending pain, heavy after dysentery.
Rhizoma Acori Graminei: there is the effects such as removing dampness appetizing, eliminating phlegm of having one's ideas straightened out, refreshment Fructus Alpiniae Oxyphyllae.Cure mainly: epilepsy, syncope due to accumulation of phlegm, burning pain coma, forgetful, deafness with qi stagnation, ambition is unhappy, stomachache, stomachache, anemofrigid-damp arthralgia, swollen ulcer drug, traumatic injury.Rhizoma Acori Graminei volatile oil (beta-Asarone) has the effect making coronary vasodilation under finite concentration, the clinical treatment being usually used in coronary heart disease, pulmonary heart disease etc. and belonging to the stagnant thoracic obstruction person of expectorant foul smell, its mechanism may to increase coronary flow relevant with it, also may with calm, improve digestive function, relieving asthma, antitussive etc. acts on relevant.
Radix Gentianae Macrophyllae: acrid in the mouth, hardship, property is put down; Return stomach, liver, gallbladder meridian.There is wind-damp dispelling, clearing away damp-heat, the effects such as stopping numbness pain.Cure mainly: the contracture of muscle arteries and veins, joint is ached, and day feeds hectic fever, and infantile malnutrition generates heat.
Radix Angelicae Sinensis: sweet in the mouth, pungent, warm in nature; Return liver, the heart, spleen channel.Have and enrich blood, invigorate blood circulation, menstruction regulating and pain relieving, moisturize the effects such as laxation.Cure mainly: menoxenia; Amenorrhea; Dysmenorrhea; Lump in the abdomen knot is poly-; Metrorrhagia; Asthenia cold abdominalgia; Flaccidity syndrome and arthralgia syndrome; Numbness of the skin; Dryness of the intestine dyschezia; Heavy after bloody dysentery; Ulcer sores; Injury from falling down.
Beneficial effect: Chinese medicine of the present invention is based on to the pathogenetic understanding of cardiovascular and cerebrovascular disease and Therapeutic Principle, the Chinese medicine using Chinese tradition is raw material, and it is formulated by clinic tests and repeated verification, scientific formula is reasonable, compatibility is original, there is blood circulation promoting and blood stasis dispelling, the effects such as sensible QI and blood, expansible blood vessel, increase blood flow, improve cardiovascular and cerebrovascular circulation, meet the theory of Chinese medicine, evident in efficacy to cardiovascular and cerebrovascular disease, and manufacture method is simple and easy to do, taking convenience, short treating period, instant effect, have no side effect, and can not drug dependence be formed, there is good economy profit social benefit.
Detailed description of the invention
Below in conjunction with specific embodiment, the present invention will be further described.
Embodiment 1:
Treating the Chinese medicine of cardiovascular and cerebrovascular disease described in the present embodiment, is be made up of following composition of raw materials: Rhizoma Chuanxiong 10 parts, 10 parts, Flos Carthami, Sanguis Draxonis 10 parts, Radix Notoginseng 15 parts, Radix Salviae Miltiorrhizae 5 parts, Hirudo 15 parts, Lignum Dalbergiae Odoriferae 10 parts, Radix Paeoniae Rubra 5 parts, Radix Puerariae 5 parts, Folium Ginkgo 5 parts, the Radix Astragali 10 parts, Radix Panacis Quinquefolii 5 parts, 3 parts, Moschus, Radix Achyranthis Bidentatae 10 parts, Bulbus Allii Macrostemonis 5 parts, Rhizoma Acori Graminei 5 parts, Radix Gentianae Macrophyllae 10 parts, Radix Angelicae Sinensis 5 parts.
Embodiment 2:
Treating the Chinese medicine of cardiovascular and cerebrovascular disease described in the present embodiment, is be made up of following composition of raw materials: Rhizoma Chuanxiong 15 parts, 15 parts, Flos Carthami, Sanguis Draxonis 15 parts, Radix Notoginseng 20 parts, Radix Salviae Miltiorrhizae 10 parts, Hirudo 20 parts, Lignum Dalbergiae Odoriferae 15 parts, Radix Paeoniae Rubra 10 parts, Radix Puerariae 10 parts, Folium Ginkgo 10 parts, the Radix Astragali 15 parts, Radix Panacis Quinquefolii 10 parts, 5 parts, Moschus, Radix Achyranthis Bidentatae 15 parts, Bulbus Allii Macrostemonis 10 parts, Rhizoma Acori Graminei 10 parts, Radix Gentianae Macrophyllae 15 parts, Radix Angelicae Sinensis 10 parts.
Embodiment 3:
Treat the Chinese medicine of cardiovascular and cerebrovascular disease described in the present embodiment, be made up of following composition of raw materials: Rhizoma Chuanxiong 12 parts, 12 parts, Flos Carthami, Sanguis Draxonis 12 parts, Radix Notoginseng 18 parts, Radix Salviae Miltiorrhizae 8 parts, Hirudo 18 parts, Lignum Dalbergiae Odoriferae 12 parts, Radix Paeoniae Rubra 8 parts, Radix Puerariae 8 parts, Folium Ginkgo 8 parts, the Radix Astragali 12 parts, Radix Panacis Quinquefolii 8 parts, 4 parts, Moschus, Radix Achyranthis Bidentatae 12 parts, Bulbus Allii Macrostemonis 8 parts, Rhizoma Acori Graminei 8 parts, Radix Gentianae Macrophyllae 12 parts, Radix Angelicae Sinensis 8 parts.
[clinical efficacy summary]:
One, we are extensive in clinical practice for many years, treatment hundreds of example patient, evident in efficacy.
Two, administrated method: first weighed all taste raw material of Chinese medicine according to formula; Then, by all taste Chinese medicine mix homogeneously, grind to form smalls, after stirring, make capsule; Every day, warm water was taken 2-3 time, each 3-5 capsules, a course for the treatment of on the 5th.
Three, therapeutic effect: the Chinese medicine using treatment cardiovascular and cerebrovascular disease of the present invention, in the clinical practice of Shouguang People's Hospital of Shandong Province in the treatment of Patients with Cardiovascular/Cerebrovascular Diseases, accept cardiovascular patient 116 example in June ,-2014 in October, 2012 altogether for medical treatment, cerebrovascular patients 97 example.213 patients take Chinese medicinal capsule preparation of the present invention by above-mentioned administrated method.Take medicine after half a year, tracing observation result: cured person (namely clinical symptoms thoroughly disappears, and has no recidivist) 121 example, accounts for 57%; Effective person (namely clinical symptoms disappears substantially, and focus is basicly stable) 83 example, accounts for 39%; Responder (namely clinical symptoms is obviously alleviated) 6 example, accounts for 3%; Nonresponder's (namely clinical symptoms is not improved) 3 example, accounts for 1%.
[case-data]:
Medical record 1:
Open * *, Changyi City of Shandong Province patient, man, 59 years old.Time medical, clinical symptoms is: uncomfortable in chest, cardiopalmus, angina pectoris, be diagnosed as coronary heart disease.After taking 2 courses for the treatment of of Chinese medicinal capsule preparation of the present invention by above-mentioned administrated method, clinical symptoms is clearly better, after continuing to take 3 courses for the treatment of of described Chinese medicine, various clinical symptoms all disappears, when following up a case by regular visits to medication half a year after drug withdrawal, have no recurrence, coronary heart disease is fully recovered.
Medical record 2:
Appoint * *, Shouguang City of Shandong Province patient, female, 64 years old.Time medical, clinical symptoms is: consciousness, visual disorder, paresis or hemiplegia, inclined side sensory disturbance, speech disorder, movement disorder, is diagnosed as cerebral thrombosis.After taking 3 courses for the treatment of of Chinese medicinal capsule preparation of the present invention by above-mentioned administrated method, clinical symptoms is clearly better, after continuing to take 3 courses for the treatment of of described Chinese medicine, various clinical symptoms all disappears, after drug withdrawal to medication half a year with time anti-, have no recurrence, cerebral thrombosis is fully recovered.
Medical record 3:
Poplar * *, Weifang City of Shandong Province Weicheng District patient, female, 53 years old.Time medical, clinical symptoms is: dizziness, headache, hypomnesis, autonomic nervous dysfunction, be diagnosed as cerebral arteriosclerosis.After taking 2 courses for the treatment of of Chinese medicinal capsule preparation of the present invention by above-mentioned administrated method, clinical symptoms is clearly better, after continuing to take 2 courses for the treatment of of described Chinese medicine, various clinical symptoms all disappears, when following up a case by regular visits to medication half a year after drug withdrawal, have no recurrence, cerebral arteriosclerosis is fully recovered.

Claims (2)

1. treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is characterized in that: it is made up of following composition of raw materials: Rhizoma Chuanxiong 10-15 part, Flos Carthami 10-15 part, Sanguis Draxonis 10-15 part, Radix Notoginseng 15-20 part, Radix Salviae Miltiorrhizae 5-10 part, Hirudo 15-20 part, Lignum Dalbergiae Odoriferae 10-15 part, Radix Paeoniae Rubra 5-10 part, Radix Puerariae 5-10 part, Folium Ginkgo 5-10 part, Radix Astragali 10-15 part, Radix Panacis Quinquefolii 5-10 part, Moschus 3-5 part, Radix Achyranthis Bidentatae 10-15 part, Bulbus Allii Macrostemonis 5-10 part, Rhizoma Acori Graminei 5-10 part, Radix Gentianae Macrophyllae 10-15 part, Radix Angelicae Sinensis 5-10 part.
2. treat the Chinese medicine of cardiovascular and cerebrovascular disease according to claim 1, it is characterized in that: it is made up of following composition of raw materials: Rhizoma Chuanxiong 12 parts, 12 parts, Flos Carthami, Sanguis Draxonis 12 parts, Radix Notoginseng 18 parts, Radix Salviae Miltiorrhizae 8 parts, Hirudo 18 parts, Lignum Dalbergiae Odoriferae 12 parts, Radix Paeoniae Rubra 8 parts, Radix Puerariae 8 parts, Folium Ginkgo 8 parts, the Radix Astragali 12 parts, Radix Panacis Quinquefolii 8 parts, 4 parts, Moschus, Radix Achyranthis Bidentatae 12 parts, Bulbus Allii Macrostemonis 8 parts, Rhizoma Acori Graminei 8 parts, Radix Gentianae Macrophyllae 12 parts, Radix Angelicae Sinensis 8 parts.
CN201410571208.9A 2014-10-17 2014-10-17 Traditional Chinese medicine for treating cardio-cerebrovascular diseases Pending CN104288464A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410571208.9A CN104288464A (en) 2014-10-17 2014-10-17 Traditional Chinese medicine for treating cardio-cerebrovascular diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410571208.9A CN104288464A (en) 2014-10-17 2014-10-17 Traditional Chinese medicine for treating cardio-cerebrovascular diseases

Publications (1)

Publication Number Publication Date
CN104288464A true CN104288464A (en) 2015-01-21

Family

ID=52308575

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410571208.9A Pending CN104288464A (en) 2014-10-17 2014-10-17 Traditional Chinese medicine for treating cardio-cerebrovascular diseases

Country Status (1)

Country Link
CN (1) CN104288464A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012388A (en) * 2015-08-13 2015-11-04 张永煜 Traditional Chinese medicine composition preventing and curing cardiovascular and cerebrovascular diseases and preparation method thereof
CN105477380A (en) * 2015-12-16 2016-04-13 牛鸿祥 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine
CN107184760A (en) * 2017-06-06 2017-09-22 黑龙江中医药大学 Chinese medicine composition for treating angiocardiopathy and preparation method thereof
CN108498755A (en) * 2018-04-17 2018-09-07 贾洪章 Treat the Chinese medicine composition and its preparation method and application of cardiovascular and cerebrovascular disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008093848A1 (en) * 2007-02-02 2008-08-07 Sunstar Inc. Composition for decreasing inflammation marker comprising phosphatidylcholine
CN102861139A (en) * 2012-09-12 2013-01-09 王萍 Health care traditional Chinese medicine composition for preventing cardia-cerebrovascular disease

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008093848A1 (en) * 2007-02-02 2008-08-07 Sunstar Inc. Composition for decreasing inflammation marker comprising phosphatidylcholine
CN102861139A (en) * 2012-09-12 2013-01-09 王萍 Health care traditional Chinese medicine composition for preventing cardia-cerebrovascular disease

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
吕永华等: "消栓通脉汤治疗缺血性脑血管病30例", 《山东中医杂志》 *
杨建峰: "《本草纲目精华》", 28 February 2014, 江西科学技术出版社 *
翟秀芹等: "外贴内服法治疗冠心病心绞痛208例", 《中医杂志》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105012388A (en) * 2015-08-13 2015-11-04 张永煜 Traditional Chinese medicine composition preventing and curing cardiovascular and cerebrovascular diseases and preparation method thereof
CN105012388B (en) * 2015-08-13 2019-12-06 张永煜 A Chinese medicinal composition for preventing and treating cardiovascular and cerebrovascular diseases, and its preparation method
CN105477380A (en) * 2015-12-16 2016-04-13 牛鸿祥 Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine
CN107184760A (en) * 2017-06-06 2017-09-22 黑龙江中医药大学 Chinese medicine composition for treating angiocardiopathy and preparation method thereof
CN108498755A (en) * 2018-04-17 2018-09-07 贾洪章 Treat the Chinese medicine composition and its preparation method and application of cardiovascular and cerebrovascular disease
CN108498755B (en) * 2018-04-17 2021-04-09 贾洪章 Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases, and its preparation method and application
US11369653B2 (en) 2018-04-17 2022-06-28 Hongzhang Jia Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular disease, preparation method therefor and use thereof

Similar Documents

Publication Publication Date Title
CN101254272B (en) Medicament for promoting coronary circulation and embolism resistance
CN103816498A (en) Traditional Chinese medicine mixture for treating sleep disorders
CN104606513A (en) Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine
CN105561214A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN103520694A (en) Traditional Chinese medicine composition capable of treating chronic obstructive pulmonary disease in stabilization period and preparation method of composition
CN104825801A (en) TCM (traditional Chinese medicine) preparation for preventing and treating cardiovascular and cerebrovascular diseases
CN104288464A (en) Traditional Chinese medicine for treating cardio-cerebrovascular diseases
CN104173773A (en) Preparation with functions of treating migraine, dispelling wind and promoting blood circulation and preparation methods
CN105343466A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN100512852C (en) Composite Chinese medicine took orally for treating coronary heart disease
CN105056133A (en) Traditional Chinese medicine pills for treating fibromyalgia syndrome and preparing method of traditional Chinese medicine pills
CN102579610B (en) Chinese medicinal composition for treating cerebral hemorrhage and preparation method thereof
CN102198228A (en) Chinese medicinal preparation for treating hypertension
CN103919910A (en) Medicine for treating coronary heart disease
CN103893670A (en) Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases
CN103610936B (en) A kind of Chinese medicine preparation and preparation method for the treatment of coronary heart disease
CN104474129A (en) Medicinal formula for treating coronary heart disease and use method thereof
CN102935162B (en) Pills for retrobulbar neuritis and preparation method
CN104189714A (en) Traditional Chinese medicine capsule for treating coronary heart disease
CN104906399A (en) Traditional Chinese medicine pills for treating heart disease and preparation method of traditional Chinese medicine pills
CN104800610A (en) Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof
CN104840874A (en) Traditional Chinese medicine pills used for aneurysm postoperative rehabilitation treatment and preparation method thereof
CN104666999A (en) Traditional Chinese medicine formula capable of reducing blood pressure
CN104524461A (en) Medicine composition for treating myocarditis and application thereof
CN104224962A (en) Traditional Chinese medicine composition for treating interstitial cystitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150121